Are Australians able to access new medicines on the pharmaceutical benefits scheme in a more or less timely manner? An analysis of pharmaceutical benefits advisory committee recommendations, 1999-2003.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples